In contrast, previous in vitro studies and the gene expression profiling of advanced ovarian cancer suggest that FGF2 acts as an autocrine growth factor for ovarian cancer cell proliferation [9]–[11] and invasion [12]. This evidence concerns the gene FGF2 and ovarian cancer.